| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,014 | 11,608 | 9,872 | 8,715 | | Cost of Revenue | 1,367 | 1,229 | 1,032 | 1,205 | | | Gross Profit | 21,647 | 10,379 | 8,840 | 7,510 | | | Operating Expenses | | Research Development | 9,300 | 10,024 | 10,021 | 9,520 | | Selling General and Administrative | 10,931 | 9,945 | 9,002 | 9,399 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,416 | (9,590) | (10,183) | (11,409) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 181 | 236 | 314 | 478 | | Earnings Before Interest And Taxes | 1,597 | (9,354) | (9,869) | (10,931) | | Interest Expense | 240 | 263 | 285 | 301 | | Income Before Tax | 1,357 | (9,617) | (10,154) | (11,232) | | Income Tax Expense | (16) | (2) | 1 | (3) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,373 | (9,615) | (10,155) | (11,229) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,373 | (9,615) | (10,155) | (11,229) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (3) | | | Net Income Applicable To Common Shares | $1,373 | ($9,615) | ($10,155) | ($11,232) |
|
1.52% Nasdaq 
Income Statement
